These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3817604)

  • 21. The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes.
    Osterud B; Eskeland T
    FEBS Lett; 1982 Nov; 149(1):75-9. PubMed ID: 7152036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
    J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H; Norpoth T; Michaels MA
    Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral contraception and surgery].
    Houssel P; Gouezec H; Malledant Y; Nolain E; Le Bouquin V; Orain C; Saint-Marc C
    Cah Anesthesiol; 1989 Oct; 37(6):451-4. PubMed ID: 2691023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects on mortality of the use of combined oral contraceptives.
    Oldfield K; Milne R; Vessey M
    Br J Fam Plann; 1998 Apr; 24(1):2-6. PubMed ID: 9719700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine.
    Carlesen E; Prydz H
    Transplantation; 1987 Apr; 43(4):543-8. PubMed ID: 3576672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prednisolone disposition and protein binding in oral contraceptive users.
    Boekenoogen SJ; Szefler SJ; Jusko WJ
    J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human factor VII associated with endotoxin stimulated monocytes in whole blood.
    Osterud B; Bjørklid E
    Biochem Biophys Res Commun; 1982 Sep; 108(2):620-6. PubMed ID: 7150311
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of endotoxin stimulation of monocytes in whole blood.
    Osterud B; Olsen JO; Wilsgard L
    Adv Exp Med Biol; 1990; 256():389-98. PubMed ID: 2109507
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma resistance to activated protein C: an important link between venous thromboembolism and combined oral contraceptives--a short review.
    Jespersen J
    Eur J Contracept Reprod Health Care; 1996; 1(1):3-11. PubMed ID: 9678132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased thromboplastin activity in circulating monocytes and reduced in vitro sensitivity to stimuli of blood monocytes from selenium-deficient rats.
    Ringstad J; Osterud B
    Thromb Res; 1988 Sep; 51(5):557-62. PubMed ID: 3175992
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.